Neurology Publications
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration;
Asken, BM, Ljubenkov, PA, Staffaroni, AM, Casaletto, KB, Vandevrede, L, Cobigo, Y, Rojas-Rodriguez, JC, Rankin, KP, Kornak, J, Heuer, H, Shigenaga, J, Appleby, BS, Bozoki, AC, Domoto-Reilly, K, Ghoshal, N, Huey, E, Litvan, I, Masdeu, JC, Mendez, MF, Pascual, B, Pressman, P, Tartaglia, MC, Kremers, W, Forsberg, LK, Boeve, BF, Boxer, AL, Rosen, HJ & Kramer, JH 2023, , Journal of Neurology, Neurosurgery and Psychiatry, vol. 94, no. 7, pp. 541-549. https://doi.org/10.1136/jnnp-2022-330866
BBox-Guided Segmentor: Leveraging expert knowledge for accurate stroke lesion segmentation using weakly supervised bounding box prior;
Ou, Y, Huang, SX, Wong, KK, Cummock, J, Volpi, J, Wang, JZ & Wong, ST 2023, , Computerized Medical Imaging and Graphics, vol. 107, 102236, pp. 102236. https://doi.org/10.1016/j.compmedimag.2023.102236
Predictive value of abbreviated olfactory tests in prodromal Parkinson disease;
the PARS Investigators 2023, , npj Parkinsons Disease, vol. 9, no. 1, 103, pp. 103. https://doi.org/10.1038/s41531-023-00530-z
A prognostic matrix code defines functional glioblastoma phenotypes and niches;
Vishnoi, M, Dereli, Z, Yin, Z, Kong, EK, Kinali, M, Thapa, K, Babur, O, Yun, K, Abdelfattah, N, Li, X, Bozorgui, B, Rostomily, RC & Korkut, A 2023, , bioRxiv. https://doi.org/10.1101/2023.06.06.543903
Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial;
Huntington Study Group KINECT-HD Collaborators 2023, , The Lancet Neurology, vol. 22, no. 6, pp. 494-504. https://doi.org/10.1016/S1474-4422(23)00127-8
Dose Optimization of Apomorphine Sublingual Film for off Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?;
Hauser, RA, Ondo, WG, Zhang, Y, Bowling, A, Navia, B, Pappert, E & Isaacson, SH 2023, , Journal of Parkinsons disease, vol. 13, no. 3, pp. 403-414. https://doi.org/10.3233/JPD-223537
Geopolitical Considerations for Working with Medically Complex Patients: A Case Illustration;
Stinson, JM, Román, CAF, Combs, HL, York, MK, Strutt, AM & McCauley, SR 2023, , Archives of Clinical Neuropsychology, vol. 38, no. 3, pp. 387-394. https://doi.org/10.1093/arclin/acad004
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study;
MG0003 study team 2023, , The Lancet Neurology, vol. 22, no. 5, pp. 383-394. https://doi.org/10.1016/S1474-4422(23)00077-7
Baseline Clinical and Blood Biomarkers in Patients With Preataxic and Early-Stage Disease Spinocerebellar Ataxia 1 and 3;
READISCA Consortium Collaborators 2023, , Neurology, vol. 100, no. 17, pp. E1836-E1848. https://doi.org/10.1212/WNL.0000000000207088
Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family;
Wilson, LMQ, Saba, S, Li, J, Prasov, L & Miller, JML 2023, , Genes, vol. 14, no. 4, 931. https://doi.org/10.3390/genes14040931